Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the ras or sis oncogenes requires the continuous expression of a second collaborating oncogene, such as adenovirus-5 ElA or SV40 large T-antigen. Our studies suggest that the function of the nuclear collaborators is to antagonize dominant growth controls which limit the ability of REF52 cells to proliferate in response to mitogenic stimuli.
Introduction
Oncogenes are genes implicated in carcinogenesis by virtue of their associations with oncogenic viruses and tumor-specific chromosome abnormalities and by their ability to transform cultured cells to a tumorigenic state (1, 2) . Mutations and virus associations enable oncogenes to facilitate autonomous cell growth either by increasing the expression of activities that promote cell proliferation or by interfering with controls that normally serve to restrict cell growth. As carcinogenesis is generally believed to be a multistep process, malignant phenotypes may frequently require multiple alterations affecting several levels of growth control (3) . This is supported by gene-transfer experiments in which two or more oncogenes are required to transform normal cells to a malignant state (4) (5) (6) .
Collaborations between oncogenes indicate that regulatory mechanisms that preclude transformation by one oncogene can be circumvented by a second oncogene. This implies that certain oncogenes actively influence the way that cells respond to other oncogenes. Gene transfer experiments indicate that expression of an activated ras oncogene is sufficient to transforn cells from a variety of established cell lines (7) (8) (9) . In contrast, primary and early passage rodent cells are transformed by ras oncogenes only at very low frequencies unless cotransfected with collaborating genes such as ElA or myc (9, 10) .
Several observations suggested that in vitro establishment is a necessary prerequisite to transformation by ras oncogenes. First, the susceptibility of normal hamster cells to transformation by ras coincides with in vitro establishment (9) . Second, genes such as ElA, p53, SV40 large T-antigen, and myc, which collaborate with ras to transform primary cells, also facilitate immortalization (11) (12) (13) (14) (15) . Finally, mutational analysis of ElA revealed a tendency for mutations that affect in vitro establishment functions to also influence the ability of ElA to collaborate with ras in the transformation of primary cells (16, 17) . However, some ElA genes are defective in immortalization but are nevertheless able to collaborate with ras in transformation (17) (18) (19) .
Though informative, the use of primary cells in transformation studies has several limitations. First, a variety of factors including variations in cell type, levels of ras expression, inhibitory effects of normal cells, and other environmental factors can influence transformation by ras alone (20) (21) (22) (23) (24) . Second, the fact that immortalization appears to be a necessary prerequisite for oncogenic transformation in vitro may simply reflect difficulties imposing a transformed phenotype over a dominant commitment to senesce. Finally, problems working with nonestablished cell clones complicate any assessment of the phenotypic effects of ras alone. As a result, the mechanisms responsible for oncogene cooperation in 
Multistep Transformation of REF52 Cells
In earlier studies, REF52 cells were transfected with T24-Ha-ras linked to the neomycin-resistance gene and clones were selected in G418. The vast majority of the resistant clones were morphologically indistinguishable from the parental line, unable to grow in soft agar, not tumorigenic in nude mice, and expressed low levels of p21T24Ha-ras (30% ofthe level of endogenous Ha-ras p21).
While 1 in 1000 clones was morphologically transformed, these rare ras-only transformants experienced morphological crisis and ceased growing. p21T24Ha-ras levels in these abortive transformants were extremely high (greater than 100-fold higher than the endogenous Haras p21), indicating that even high levels ofthe activated ras oncoprotein are not sufficient to induce stable transformation in the absence of a collaborating oncogene (25) .
In contrast, cells transfected with T24Ha-ras/neo and either adenovirus E1A or SV40 large T-antigen, gave rise to transformed neo-resistant colonies (25, 27) . While p21T24Ha-r,S levels in these transformed clones varied considerably, ranging from levels 2-to 10-fold greater than the endogenous p21l-Ha-ra8 all of the transformed clones tested formed colonies in soft agar and induced rapidly lethal tumors in nude mice. These studies indicate that relatively low levels of the oncogenic p21 are sufficient to transform in the presence of a collaborator and that the collaborating oncogene supplies activities that are not duplicated by increased ras expression.
Conditional transformation of REF52 cells has also been achieved by cotransfecting a temperature-sensitive allele of SV40 large T-antigen (tsA58) and T24 Haras (27 To investigate early phenotypic effects of ras, activated and normal forms of p21 were introduced into serum-arrested REF52 cells using the bead-loading method (28) . The method utilizes small (75-500 ,um) glass beads to mechanically disrupt the plasma membrane to an extent that allows proteins to enter cells without significantly affecting cell viability. p21Ha,-s proteins were purified from insect cells infected with baculovirus vectors expressing high levels of posttranslationally modified T24 and c-Ha-ras p2ls. As shown in Figure 1 , up to 31% of the cells loaded in the presence of a 2.2 mg/mL solution of the activated p21 were stimulated to enter S phase within 24 hr, whereas cells loaded with bovine serum albumin failed to respond. Introduction of nonactivated c-Ha-ras p21 was less effective in stimulating cell cycle progression than activated p21 (data not shown). Maximum incorporation of 3H-thymidine was observed 12 to 24 hr after exposure to bead loaded p21T24Ha-ras. At concentrations greater Protein Concentration (mg/ml) FIGURE 1. Bead-loaded T24ras p21 stimulates serum-arrested REF52 cells to progress through the cell cycle. REF52 cells, seeded on glass coverslips, were transferred to Dulbecco's modified Eagle's media containing 1% ITS+ (insulin, transferrin selenium, and oleic acid/bovine serum albumin complex). After 48 hr, growth-arrested REF52 cells were washed with phosphatebuffered saline (PBS), covered with 50 ,L PBS containing varying amounts of T24ras p21, or bovine serum albumin (BSA), and were bead-loaded using 75-to 150-Rm beads, as described (28) . BSA loaded at 3.6 mg/mL resulted in 0.1% labeled nuclei. Cells were labeled with 2.5 ,uCi/mL 3H-thymidine for 24 hr post-bead-loading and then fixed and processed for emulsion autoradiography.
than 1 mg/mL, p21r24Ha-ras also induced morphological transformation as well as stimulating DNA replication. Similar results have been reported using microinjected p21 (29) ; thus, although resistant to transformation, REF52 cells are mitogenically stimulated by introduction of p21T24Ha-ras. In this regard, REF52 cells respond to oncogenic p21 in a manner not unlike cells that are susceptible to transformation (29, 30) . As ras is thought to transduce signals from growth factor receptors, controls that prevent ras from transforming REF52 cells would appear to act at a level subsequent to or independent of a mitogenic response to ras.
ElA Enables the sis Oncogene to Transform REF52 Cells Similar growth controls may also regulate transformation of REF52 by c-sis, the B chain of the plateletderived growth factor (PDGF) (31, 32) . Transformation by sis is thought to result from autocrine stimulation resulting from binding to the growth factor to PDGF receptors.
Quiescent REF52 cells were stimulated to enter S phase by recombinant p28c"s, indicating that these cells have receptors for PDGF (Fig. 2) . In addition, p28'-ss induced, with expected kinetics, the transcription of several growth factor-induced early response genes (i.e., igc,fos, and JE), suggesting that the signal transduction pathway from the cell surface to the nucleus is intact (data not shown). However, when REF52 cells are cotransfected with c-sis and the gene for neomycin resistance, all of the resistant colonies were indistinguishable from REF52 cells transfected with the neomycin-resistance gene alone. In each case, similar numbers of neo-resistant colonies were obtained, suggesting that the sis gene was not toxic to REF52 cells. E1A introduced together (Table 1 ) or in a secondary transfection (data not shown), enabled c-sis to transform REF52 cells to anchorage independence. These results suggest that the ability of cells to be mitogenically stimulated by sis growth factor, while perhaps necessary, was not sufficient for stable transformation. As with ras, ElA appears to circumvent controls that prevents sustained exposure to a mitogenic stimulus from transforming.
Collaborating Oncogenes Have Complementary Effects on Cellular Responses to Growth Factors
Since oncogenic transformation of REF52 cells can require the activities of two oncogenes acting in concert, these cells provide an opportunity to study the biological effects of individual oncogenes in the absence of secondary phenotypic changes resulting from transformation. REF52 cells expressing low levels of activated Ha-ras p21 (T24REF) are morphologically normal and fail to form either colonies in soft agar or tumors in nude mice. However, these cells express functional ras oncoproteins, since ElA and SV40 large T-antigen each efficiently transform when transfected subsequently (clone N6) (25) .
When transferred to serum-free media, T24REF (clone RN14) cells cease growing with kinetics indistinguishable from the neo-resistant REF52 control (clone N6) (Fig. 3) . Nevertheless, a marked difference was evident between the cell lines upon restimulation by individual mitogens. As shown in Figure 2 , the presence of even low levels of activated p21 interfered with the ability of REF52 cells to progress into S phase upon stimulation by phorbol 12-myristate 13-acetate, epidermal growth factor, PDGF or PDGF and epidermal growth factor together. The response to serum, however, was unaffected or even moderately enhanced by T24Ha-ras.
Cell lines individually expressing either ElA or SV40 large T antigen, although morphologically altered, were not transformed, as assessed by their failure to grow in soft agar or from tumors in nude mice. However, as shown in Figure 2 , the presence of either SV40 large T antigen or ElA in REF52 cells allows for extended proliferation in the absence of serum growth factors. Thus, there is an apparent functional complementation: ras inhibits proliferative responses to mitogenic stimuli, while ElA and large T each enable REF52 cells to proliferate in the absence of mitogenic stimuli. In other words, REF52 cells appear to possess growth controls (20) , pSMRlMoNeo, a derivative of pSMl (42) , c-sis and neo genes expressed from the SV40 early promoter and moloney murine leukemia virus LTR, respectively; plA, advenovirus-5 ElA (25); and plAhgm, Ad5 ElA and hygromycin resistance gene. Following selection with 0.4 mg/mL G418 (Gibco, 50% active) and/or 0.1 mg/mL hygromycin B (Calbiochem), cells from at least 100 colonies were trypsinized, pooled, and plated in media containing 0.37% agarose. Fresh agar-containing media was added to soft agar cultures once a week for 3 to 4 weeks and then the cultures were stained with p-iodonitrotetrazolium violet (Sigma). Soft agar plating efficiency refers to percent of cells forming colonies 70 jLm in diameter or larger. Table 2 , containing either hygromycin or neomycin resistance markers, were fused using polyethylene glycol and selected in the presence of both antibiotics (33) . Hybrid colonies were pooled and plated in soft agar to assess whether any expressed transformed phenotypes (Table 3) .
When NRK cells transformed by ras were fused with REF52 cells, 20-fold fewer colonies were obtained than when normal NRK cells were fused with REF52. Furthermore, the hybrid colonies obtained were morphologically nonnal and failed to produce any soft agar colonies, indicating that transformation of NRK cells by ras was suppressed by fusion with REF52 cells. In contrast, the fusion of ras-transformed NRK cells with ElA-expressing REF52 cells yielded transformed colonies, which formed colonies in soft agar with a frequency of 4%. Similar results were obtained with Rat2 cells were substituted for NRK cells (Table 3) . Thus, the growth controls that prevent ras from transforming and act to inhibit proliferation in the presence of ras are dominant, trans-acting, and are either circumvented or negated by function(s) of ElA.
Further evidence that REF52 cells possess a dominant antagonist of transformation has come from the analysis of spontaneous transformants induced by activated ras oncogenes. We pooled 102 to 104 to neomycin-resistant colonies isolated after transfecting REF52 cells with T24Ha-ras, and 5 x 106 cells were injected into nude mice. Tumors arose within 4 to 6 weeks, and the cell lines derived from each tumor were Tables 1 and 2 and in text. Fusions between REF52 cells and ras-transformed REF52 cells isolated by in vivo selection failed to produce transformed hybrids. ND, not determined. ras to transform primary baby rat kidney cells (34) (35) (36) .
This raises the possibility that p1O5Rb is a component of the transformation antagonist of REF52 cells. If so, one would expect to observe differences in the levels of plO5Rb in normal REF52 cells, and ras-transformed REF52 tumor cells. However, the eight ras-induced tumor lines examined thus far maintain a normal number of intact Rb genes as well as unaltered levels of Rb message. These results do not exclude the possibility of point-mutations or posttranslational alterations that adversely affect the activity of p105Rb.
Summary
In summary, REF52 cells possess growth controls that prevent a sustained mitogenic stimulus from transforming. These growth controls are dominant and can act in trans to antagonize transformation of rat cells previously transformed by ras. Given that ras and sis initially provoke REF52 cells to proliferate, the antagonist may itself be activated by mitogens as a part of a feed-back mechanism which limits cell proliferation. ElA and SV40 large T are able to circumvent or inactivate the antagonist. The extent to which this relates to the mechanism by which the viral oncoproteins enable REF52 cells to grow in the absence of serum is currently under investigation.
Future studies will focus on genes, such as Rb and p53, known to be involved in the negative regulation of cell proliferation in an effort to understand at a biochemical level the information obtained in genetic analyses. In addition, we will examine the effects of ras on various cell-cycle genes. It is interesting that ras causes REF52 and other cells to arrest in G2 upon removal of SV40 large T-antigen (27, 37) . The control of the cells cycle in G2 has been described in a variety of organisms and can involve a protein kinase identified as: a) a component of maturation promoting factor (MPF), b) a 34 kDa protein in mammalian cells, c) a starfish histone Mphase kinase, and d) products of the CDC2 and cdc28 genes of S. pombe and S. cerevisiae, respectively (38, 39) . That ElA both induces p34 in baby rat kidney cells (40) and binds to a cyclinlike molecule (41) as well as the observation that ras-expressing REF52 cells arrest in G2 suggests that p34 may influence complementation between these oncogenes. For example, ElA may protect against the repression of p34 expression or activity by ras. This work is supported by National Cancer Institute Public Health Service grants R01CA40602 and P01CA42063 (to H.E.R.) and partially supported by a Cancer Center Core grant P30CA14051 to P.A. Sharp.
